IL1B and melanoma: In addition, a recent study by Okamoto et al. indicates that the expression and secretion of active IL-1β in melanoma becomes increasingly autonomous during disease progression, which seems to be driven by constitutive activation of the NLRP3 inflammasome (Okamoto et al., 2010).